Real-World Survival Outcomes of Glioblastoma Patients Under Universal Temozolomide Access in Uruguay: A Retrospective Cohort Study (2009-2018) and Implications for Health Policy.

Massia M, Rodriguez R, Ximenez S.

Open source

DOI
10.7759/cureus.113315
Published
2026-07-24
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.113315,
  title = {Real-World Survival Outcomes of Glioblastoma Patients Under Universal Temozolomide Access in Uruguay: A Retrospective Cohort Study (2009-2018) and Implications for Health Policy.},
  author = {Massia M and  Rodriguez R and  Ximenez S.},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.113315},
  url = {https://doi.org/10.7759/cureus.113315}
}

RIS

TY  - JOUR
TI  - Real-World Survival Outcomes of Glioblastoma Patients Under Universal Temozolomide Access in Uruguay: A Retrospective Cohort Study (2009-2018) and Implications for Health Policy.
AU  - Massia M
AU  -  Rodriguez R
AU  -  Ximenez S.
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.113315
UR  - https://doi.org/10.7759/cureus.113315
ER  - 

APA

M, M., R, R., & S., X. (2026). Real-World Survival Outcomes of Glioblastoma Patients Under Universal Temozolomide Access in Uruguay: A Retrospective Cohort Study (2009-2018) and Implications for Health Policy.. Cureus. https://doi.org/10.7759/cureus.113315

Source records